Sugi Predict

Sugi Predict / Compounds / SCHEMBL3514843

SCHEMBL3514843

SCHEMBL3514843

Cc1nn(C)cc1-n1c(=O)[nH]c2cnc3ccc(Br)cc3c21

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CASP3 P42574 3/20 0.40
▸ BRD4 O60885 2/20 0.40
▸ BRD2 P25440 2/20 0.40
▸ BRD3 Q15059 2/20 0.40
▸ CYP3A4 P08684 2/20 0.40
▸ CYP2C9 P11712 2/20 0.40
▸ HAVCR2 Q8TDQ0 1/20 0.38
▸ AURKA O14965 1/20 0.37
▸ GABRA1 P14867 1/20 0.35
▸ GABRG2 P18507 1/20 0.35
▸ GABRB3 P28472 1/20 0.35
▸ GABRA5 P31644 1/20 0.35
▸ GABRA3 P34903 1/20 0.35
▸ GABRA2 P47869 1/20 0.35
▸ GABRA6 Q16445 1/20 0.35
▸ PIK3CA P42336 3/20 0.35
▸ MTOR P42345 3/20 0.35
▸ CHEK1 O14757 1/20 0.34
▸ PIM1 P11309 1/20 0.34
▸ AKT1 P31749 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2068583 0.83 BRD4 (0.36) CASP3BRD4BRD2BRD3CYP3A4
SCHEMBL3516216 0.81 ATM (0.42) BRD4BRD2BRD3CYP3A4CYP2C9
SCHEMBL3514698 0.81 BRD4 (0.45) BRD4BRD2BRD3CYP3A4CYP2C9
SCHEMBL3516333 0.81 CASP3 (0.43) CASP3BRD4BRD2BRD3CYP3A4
SCHEMBL2068303 0.81 MTOR (0.46) BRD4BRD2BRD3CYP3A4CYP2C9
SCHEMBL3513692 0.80 IRAK4 (0.38) TP53
SCHEMBL2066048 0.80 MTOR (0.46) CASP3PIK3CAMTORCHEK1AKT1
SCHEMBL3516922 0.79 ATM (0.49) PIK3CAMTORATMATR
SCHEMBL17272559 0.78 AURKA (0.42) CASP3BRD4BRD2BRD3CYP3A4
SCHEMBL1585483 0.78 CASP3 (0.44) CASP3HAVCR2AURKAGABRA1GABRG2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20140005163-A1 1H-IMIDAZO[4,5-C]QUINOLINONE DERIVATIVES NOVARTIS AG (CH) 2014-01-02 — — US disclosed
US-8476294-B2 1H-imidazo[4,5-c]quinolinone derivatives NOVARTIS AG (CH) 2013-07-02 — — US disclosed
US-8476294-B2 1H-imidazo[4,5-c]quinolinone derivatives NOVARTIS AG (CH) 2013-07-02 — — US disclosed
US-8476294-B2 1H-imidazo[4,5-c]quinolinone derivatives NOVARTIS AG (CH) 2013-07-02 — — US disclosed
US-20100317657-A1 1H-IMIDAZO[4,5-c]QUINOLINONE DERIVATIVES NOVARTIS AG 2010-12-16 — — US disclosed
US-20100317657-A1 1H-IMIDAZO[4,5-c]QUINOLINONE DERIVATIVES NOVARTIS AG 2010-12-16 — — US disclosed
US-20100317657-A1 1H-IMIDAZO[4,5-c]QUINOLINONE DERIVATIVES NOVARTIS AG 2010-12-16 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100317657-A1 1H-IMIDAZO[4,5-c]QUINOLINONE DERIVATIVES PRKCA, CSNK1A1, ABL1 CASP3 2748/4885BRD4 277/4885BRD2 757/4885
US-20140005163-A1 1H-IMIDAZO[4,5-C]QUINOLINONE DERIVATIVES PRKCA, CSNK1A1, ABL1 CASP3 2748/4885BRD4 277/4885BRD2 757/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.